As of 2025-04-24, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 21.0x | 19.0x |
| Forward P/E multiples | 22.1x - 24.7x | 23.5x |
| Fair Price | (6.07) - (5.74) | (5.81) |
| Upside | -1843.8% - -1750.4% | -1769.4% |
| Date | EV/EBITDA |